CR Group L.P. 13D and 13G filings for T2 Biosystems, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-13 7:21 pm Purchase |
2024-05-09 | 13D | T2 Biosystems, Inc. TTOO |
CR Group L.P. | 10,677,973 69.500% |
1,824,800 (+20.61%) |
Filing |
| 2024-05-07 7:46 pm Purchase |
2024-05-03 | 13D | T2 Biosystems, Inc. TTOO |
CR Group L.P. | 8,853,173 65.400% |
4,748,335 (+115.68%) |
Filing |
| 2024-04-19 4:31 pm Purchase |
2024-04-12 | 13D | T2 Biosystems, Inc. TTOO |
CR Group L.P. | 4,104,838 46.680% |
4,104,838 (New Position) |
Filing |